| abstract |
The present invention relates to certain biologically active peptides and complex peptides that can be used as a therapeutic or prophylaxis for a disease or condition associated with B1 as an infectious agent. In a preferred embodiment of the invention, biologically active PEG-binding peptides are provided. In one aspect of the invention, the pharmaceutically active PEG-binding peptides of the invention are useful for treating infection or pain. |